Type 2 Diabetes
Q&A: What nutrition security can mean for people with diabetes
Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Isabel C. Betancourt, MS, RDN, CDCES, about nutrition insecurity and how a model designed to combat its effects on people with HIV can improve the lives of people with diabetes.
Adults with type 2 diabetes improve HbA1c, medication use with pharmacist referral
Adults with type 2 diabetes who are referred to a clinical pharmacist are more likely to meet their HbA1c goal and receive appropriate medication management of comorbidities than people receiving usual care, according to a presenter.
GLP-1 use tied to lower risk for hyperkalemia than DPP-IV therapy in type 2 diabetes
Adults with type 2 diabetes using a GLP-1 receptor agonist are less likely to develop hyperkalemia than those using a DPP-IV inhibitor, according to a study published in JAMA Internal Medicine.
Tirzepatide linked to lower risk for death, adverse CV and kidney outcomes vs. GLP-1s
Adults with type 2 diabetes have lower risks for death and major adverse cardiovascular and kidney events if they use tirzepatide compared with GLP-1 receptor agonists, according to observational data published in JAMA Network Open.